Weightloss

Compounded Semaglutide

Semaglutide was originally approved by the FDA approved in 2014 for Type 2 diabetes to lower blood sugar and maintain blood sugar levels. Over time, it was discovered that Semaglutide had other benefits such as improved cardiovascular risk, decreased inflammation, decreased appetite, and thus weight loss. Semaglutide was FDA approved in 2019 for use in patients with a BMI of 30 or greater, or a BMI of 27 and greater with at least one comorbidity, for weight management.

Semaglutide is a glucagon-like peptide-1 receptor agonist. It mimics the action of the incretin GL-1 by increasing the production of insulin or a hormone that lowers blood sugar levels. Semaglutide works by suppressing your appetite, and the peptide semaglutide mimics acts on the areas in the brain that regulate appetite and food intake. The peptide semaglutide imitates GL-1 and targets the areas in the brain that regulate appetite and food intake.
In addition to the use of Semaglutide, use of an exercise program and reduced caloric intake will help aid in weight loss goals and long-term management.

FREQUENTLY ASKED QUESTIONS

Semaglutide is a subcutaneous injection given once a week at home.

Brand names are Wegovy, Ozempic, and Rybelus. Wegovy and Ozempic are injections, and Rybelsus is a tablet.

You may experience nausea, vomiting, diarrhea, abdominal pain, and constipation. If you have heart problems, it can cause damage to your retina. Other less common side effects include elevated heart rate, allergic reactions, low blood sugar, pancreatitis, thyroid tumors, and kidney problems.

 

Dosages are based on health conditions and your response to the treatments. You might start at a low dose and gradually increase your dose. Follow your provider’s instructions. Semaglutide for weight loss is typically used for 3- 6 months.

Semaglutide is a subcutaneous injection given once a week at home.

You may experience nausea, vomiting, diarrhea, abdominal pain, and constipation. If you have heart problems, it can cause damage to your retina. Other less common side effects include elevated heart rate, allergic reactions, low blood sugar, pancreatitis, thyroid tumors, and kidney problems.

 

Dosages are based on health conditions and your response to the treatments. You might start at a low dose and gradually increase your dose. Follow your provider’s instructions. Semaglutide for weight loss is typically used for 3- 6 months.

COMPOUNDED TIRZEPATIDE

Tirzepatide was approved by the FDA in 2022 for the treatment of Type 2 diabetes to enhance glycemic control and support weight management. This approval came after studies showed that Tirzepatide not only lowers blood sugar levels but also aids in significant weight loss. A Tirzepatide program is recommended for anyone with a body mass index (BMI) of 30 or more, or with a BMI of 27 or more and at least one weight-related condition.

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It acts by enhancing the body’s natural insulin producti in response to high blood sugar levels and suppresses glucagon secretion, which together reduce blood sugar. Tirzepatide has an impact on the brain’s centers that regulate appetite, which results in reduced food intake and weight loss. If Tirzepatide is combined with a healthy diet and regular physical activity, it can significantly improve weight loss outcomes and lead to better long-term health management.

FREQUENTLY ASKED QUESTIONS

Tirzepatide is given once a week as a subcutaneous injection, which can be done at home.

Some of the most common side effects are gastrointestinal, such as nausea, vomiting, diarrhea, and abdominal pain. There can also be instances of reduced appetite and potential hypoglycemia, especially when combined with other diabetes medications. Rarer side effects may include pancreatitis, allergic reactions, and thyroid tumors.

The dosage of Tirzepatide varies based on individual health needs and response to treatment. Treatment usually starts at a lower dose, which is gradually increased based on tolerance and effectiveness. Always adhere to the dosing schedule prescribed. Tirzepatide treatment for weight management is typically recommended for a duration of 6 months or longer, depending on individual health goals and response.

Weightloss Program Pricing

Compounded Semaglutide

$500

Includes 6 weeks of medication, supplies, and consultation

Compounded Tirzepatide

$650

Includes 6 weeks of medication, supplies, and consultation

Ask Questions

PHP Code Snippets Powered By : XYZScripts.com
Call Now Button